Judith Zavala

Dr. Judith Zavala

Tecnologico de Monterrey, Monterrey, Nuevo León, Mexico
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2013 in Eye
Verified
Journal Article
Open access
Judith ZavalaJudith Zavala
Judith Zavala
GJG R López Jaime
G R López Jaime
CBC A Rodríguez Barrientos
C A Rodríguez Barrientos
JVJorge E. Valdez-Garcia
Jorge E. Valdez-Garcia
The main treatment available for restoration of the corneal endothelium is keratoplasty. This procedure is faced with several difficulties, including the shortage of donor tissue, post-surgical complications associated with the use of drugs to prevent immune rejection, and a significant increase in the occurrence of glaucoma. Recently, surgical procedures such as Descemet's stripping endothelial keratoplasty have focused on the transplant of corneal endothelium, yielding better visual results but still facing the need for donor tissue. The emergent strategies in the field of cell biology and tissue cultivation of corneal endothelial cells aim at the production of transplantable endothelial cell sheets. Cell therapy focuses on the culture of corneal endothelial cells retrieved from the donor, in the donor's cornea, followed by transplantation into the recipient. Recently, research has focused on overcoming the challenge of harvesting human corneal endothelial cells and the generation of new biomembranes to be used as cell scaffolds in surgical procedures. The use of corneal endothelial precursors from the peripheral cornea has also demonstrated to be effective and represents a valuable tool for reducing the risk of rejection in allogeneic transplants. Several animal model reports also support the use of adult stem cells as therapy for corneal diseases. Current results represent important progresses in the development of new strategies based on alternative sources of tissue for the treatment of corneal endotheliopathies. Different databases were used to search literature: PubMed, Google Books, MD Consult, Google Scholar, Gene Cards, and NCBI Books. The main search terms used were: 'cornea AND embryology AND transcription factors', 'human endothelial keratoplasty AND risk factors', '(cornea OR corneal) AND (endothelium OR endothelial) AND cell culture', 'mesenchymal stem cells AND cell therapy', 'mesenchymal stem cells AND cornea', and 'stem cells AND (cornea OR corneal) AND (endothelial OR endothelium)'.

21 November 2014 in Seminars in Ophthalmology
Verified
Journal Article
Closed access
ECEduardo Cárdenas-Cantú
Eduardo Cárdenas-Cantú
Judith ZavalaJudith Zavala
Judith Zavala
JVJorge Valenzuela
Jorge Valenzuela
JVJorge E. Valdez-Garcia
Jorge E. Valdez-Garcia
Pterygium pathogenesis is mainly related to UV light exposure. However, the exact mechanisms by which it is formed have not been elucidated. Clinical advances in surgical treatment use conjunctival autografts and amniotic membranes in combination with adjuvant therapies, including mitomycin C, β-radiation, and 5-fluoroacil, to reduce recurrence. Several studies aim to unveil the molecular mechanisms underlying pterygium growth and proliferation. They demonstrate the role of different factors, such as viruses, oxidative stress, DNA methylation, apoptotic and oncogenic proteins, loss of heterozygosity, microsatellite instability, inflammatory mediators, extracellular matrix modulators, lymphangiogenesis, cell epithelial-mesenchymal transition, and alterations in cholesterol metabolism in pterygium development. Understanding the molecular basis of pterygium provides new potential therapeutic targets for its prevention and elimination. This review focuses on providing a broad overview of what is currently known regarding molecular mechanisms of pterygium pathogenesis.

12 February 2024 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
FLFrancisco Altamirano Lamarque
Francisco Altamirano Lamarque
GMGustavo Ortiz Morales
Gustavo Ortiz Morales
MOMario A. O’cOnnor-Cordova
Mario A. O’cOnnor-Cordova
JSJuan Pablo Sancén-Herrera
Juan Pablo Sancén-Herrera
Judith ZavalaJudith Zavala
Judith Zavala
JVJorge E. Valdez-Garcia
Jorge E. Valdez-Garcia

4 February 2015 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
JVJorge E. Valdez-Garcia
Jorge E. Valdez-Garcia
JLJuan F Lozano-Ramirez
Juan F Lozano-Ramirez
Judith ZavalaJudith Zavala
Judith Zavala
Corneal endothelium engineering is focused in producing transplantable cell sheets to overcome the shortage of corneal graft tissue donors for the treatment of corneal blindness. For this purpose, the use of a proper animal model plays a key role. Corneal parameters of White New Zealand rabbits such as endothelial cell density, central corneal thickness, and corneal diameter decrease with age, similarly as in humans. However, as opposed to humans, they retain the ability to restore their corneal endothelium after injury. Therefore, they are considered as an inappropriate corneal endothelial wound healing model. Here we analyze the corneal endothelium mitotic ability of White New Zealand rabbits aged 3, 6, 12 and 18 months, 36 and 72 hours after thermal injury. The highest mitotic activity was observed in the 3-month rabbits 36 h after wounding. Rabbits of 12 months registered decreased mitotic activity and those of 18 months did not show mitotic activity 72 h after injury. These results propose that rabbits of 18 months represent a suitable model for human corneal endothelium engineering research.

5 June 2018 in Biological Research
Verified
Journal Article
Open access
PDF file
Judith ZavalaJudith Zavala
Judith Zavala
JHJulio C. Hernandez-Camarena
Julio C. Hernandez-Camarena
BSBrenda Salvador-Gálvez
Brenda Salvador-Gálvez
JPJosé E. Pérez-Saucedo
José E. Pérez-Saucedo
AVAmin Vela-Martinez
Amin Vela-Martinez
JVJorge E. Valdez-Garcia
Jorge E. Valdez-Garcia
Translational research to develop pharmaceutical and surgical treatments for pterygium requires a reliable and easy to produce animal model. Extracellular matrix and fibroblast are important components of pterygium. The aim of this study was to analyze the effect of the subconjunctival injection of fibroblast cells (NIH3T3 cell line) and exogenous extracellular matrix in rabbits in producing a pterygium-like lesion. Six 3-month-old white New Zealand rabbits were injected with 20,000 NIH3T3 cells and 5 µL of Matrigel in the right conjunctiva, and with only 5 µL of Matrigel in the left conjunctiva. The eyes were photographed under a magnification of 16× using a 12-megapixel digital camera attached to the microscope on day 1, 3 and 7. Conjunctival vascularization was measured by analyzing images to measure red pixel saturation. Area of corneal and conjunctival fibrovascular tissue formation on the site of injection was assessed by analyzing the images on day 3 and 7 using area measurement software. Histopathologic characteristics were determined in the rabbit tissues and compared with a human primary pterygium. The two treatments promoted growth of conjunctival fibrovascular tissue at day 7. The red pixel saturation and area of fibrovascular tissue developed was significantly higher in right eyes (p < 0.05). Tissues from both treatments showed neovascularization in lesser extent to that observed in human pterygium. Acanthosis, stromal inflammation, and edema were found in tissues of both treatments. No elastosis was found in either treatment. Matrigel alone or in combination with NIH3T3 cells injected into the rabbits’ conjunctiva can promote tissue growth with characteristics of human pterygium, including neovascularization, acanthosis, stromal inflammation, and edema. The combination of Matrigel with NIH3T3 cells seems to have an additive effect on the size and redness of the pterygium-like tissue developed.

29 August 2022 in Polymers
Verified
Journal Article
Open access
PDF file
MMMaría Dolores Montalvo-Parra
María Dolores Montalvo-Parra
WOWendy Ortega
Wendy Ortega
Denise Loya-GarciaDenise Loya-Garcia
Denise Loya-Garcia
ABAndres Bustamante-Arias
Andres Bustamante-Arias
GGGuillermo-Isaac Guerrero-Ramírez
Guillermo-Isaac Guerrero-Ramírez
JVJorge E. Valdez-Garcia
Jorge E. Valdez-Garcia
Corneal opacities are a leading cause of visual impairment that affect 4.2 million people annually. The current treatment is corneal transplantation, which is limited by tissue donor shortages. Corneal engineering aims to develop membranes that function as scaffolds in corneal cell transplantation. Here, we describe a method for producing transplantable corneal constructs based on a collagen vitrigel (CVM) membrane and corneal endothelial cells (CECs). The CVMs were produced using increasing volumes of collagen type I: 1X (2.8 μL/mm2), 2X, and 3X. The vitrification process was performed at 40% relative humidity (RH) and 40 °C using a matryoshka-like system consisting of a shaking-oven harboring a desiccator with a saturated K2CO3 solution. The CVMs were characterized via SEM microscopy, cell adherence, FTIR, and manipulation in an ex vivo model. A pilot transplantation of the CECs/CVM construct in rabbits was also carried out. The thickness of the CVMs was 3.65–7.2 µm. The transparency was superior to a human cornea (92.6% = 1X; 94% = 2X; 89.21% = 3X). SEM microscopy showed a homogenous surface and laminar organization. The cell concentration seeded over the CVM increased threefold with no significant difference between 1X, 2X, and 3X (p = 0.323). The 2X-CVM was suitable for surgical manipulation in the ex vivo model. Constructs using the CECs/2X-CVM promoted corneal transparency restoration.